IONIS PHARMACEUT reported $2.42B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Astellas Pharma 4503:JP JPY 2.58T 101.82B
Biocryst Pharmaceuticals BCRX:US USD 558.59M 48.06M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Exelixis EXEL:US USD 2.96B 79.97M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Moderna Inc MRNA:US USD 26.06B 13M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Novartis NOVN:VX USD 118.46B 4.45B
Omeros OMER:US USD 457.55M 111.91M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B